(8 intermediate revisions by 2 users not shown) | |||
Line 28: | Line 28: | ||
</tr> | </tr> | ||
− | <tr> | + | <tr bgcolor= "#efefef"> |
<td align="center"><h4>Adim Moreb</h4> | <td align="center"><h4>Adim Moreb</h4> | ||
<p><br>Adim is a Ph.D. student in the Biomedical Engineering department. He joined the Lynch lab in 2015. His work focuses on improving the speed and efficiency of genome engineering in bacteria.</p> | <p><br>Adim is a Ph.D. student in the Biomedical Engineering department. He joined the Lynch lab in 2015. His work focuses on improving the speed and efficiency of genome engineering in bacteria.</p> | ||
Line 45: | Line 45: | ||
</table> | </table> | ||
</font> | </font> | ||
− | + | <hr> | |
<center><h2>Mentors</h2> | <center><h2>Mentors</h2> | ||
<font size="4"> | <font size="4"> | ||
Line 52: | Line 52: | ||
<tr> | <tr> | ||
− | + | ||
<td align="center"><h4>Johnathon Burg</h4> | <td align="center"><h4>Johnathon Burg</h4> | ||
<p><br>Jonathan obtained his Ph.D. in Chemistry with Prof. Dewey G. McCafferty at Duke University concentrating his research efforts on the kinetic and biophysical characterization of KDM1A. In the Lynch Lab, Jonathan is focused on the engineering of a dynamic metabolic engineering platform for yeast, including aspects of both strain and bioprocess development.</p> | <p><br>Jonathan obtained his Ph.D. in Chemistry with Prof. Dewey G. McCafferty at Duke University concentrating his research efforts on the kinetic and biophysical characterization of KDM1A. In the Lynch Lab, Jonathan is focused on the engineering of a dynamic metabolic engineering platform for yeast, including aspects of both strain and bioprocess development.</p> | ||
</td> | </td> | ||
+ | |||
+ | <td align="center" ><img src="https://static.igem.org/mediawiki/2017/9/92/T--Duke--Burg.png" style="width:250px;height:250px;"></td> | ||
</tr> | </tr> | ||
− | <tr> | + | <tr bgcolor= "#efefef"> |
+ | <td align="center"><img src="https://static.igem.org/mediawiki/2017/b/b3/T--Duke--Zhixia.jpg" style="width:274px;height:235px;"></td> | ||
<td align="center"><h4>Zhixia Ye </h4> | <td align="center"><h4>Zhixia Ye </h4> | ||
<p><br> Zhixia was born in China and got her Ph.D. in Chemistry from NC State in 2014. She enjoys reading and traveling in her free time. Zhixia has been leading efforts aimed at developing a dynamic metabolic engineering platform in the bacterium E. coli. Zhixia's work is leading to sustainable processes for the production of numerous chemicals, natural products and natural product derivatives. </p> | <p><br> Zhixia was born in China and got her Ph.D. in Chemistry from NC State in 2014. She enjoys reading and traveling in her free time. Zhixia has been leading efforts aimed at developing a dynamic metabolic engineering platform in the bacterium E. coli. Zhixia's work is leading to sustainable processes for the production of numerous chemicals, natural products and natural product derivatives. </p> | ||
</td> | </td> | ||
− | + | ||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | |||
<td align="center"><h4>Charlie Cooper</h4> | <td align="center"><h4>Charlie Cooper</h4> | ||
<p><br>Charlie's current projects involve engineering microbes and enzymes for renewable production of bulk chemicals, pharmaceuticals, and advanced materials. He spends his spare time maintaining a collection of orchids and befriending neighborhood cats.</p> | <p><br>Charlie's current projects involve engineering microbes and enzymes for renewable production of bulk chemicals, pharmaceuticals, and advanced materials. He spends his spare time maintaining a collection of orchids and befriending neighborhood cats.</p> | ||
</td> | </td> | ||
+ | <td align="center"><img src="https://static.igem.org/mediawiki/2017/b/bb/T--Duke--Charlie.jpg" style="width:236px;height:298px;"></td> | ||
+ | |||
</tr> | </tr> | ||
− | <tr> | + | <tr bgcolor= "#efefef"> |
+ | <td align="center"><img src="https://static.igem.org/mediawiki/2017/4/49/T--Duke--Jen.jpg" style="width:242px;height:300px;"></td> | ||
<td align="center"><h4>Jennifer Hennigan</h4> | <td align="center"><h4>Jennifer Hennigan</h4> | ||
<p><br>Jen earned her BS in chemistry from Stetson University in 2015. She is a chemistry PhD student with research interests at the interface of chemistry and biomedical engineering. Her current projects include enhancing the production of pharmaceuticals in E. coli and developing advanced therapies for pancreatic cancer. In her spare time, Jen plays field hockey with the TarDevils adult team.</p> | <p><br>Jen earned her BS in chemistry from Stetson University in 2015. She is a chemistry PhD student with research interests at the interface of chemistry and biomedical engineering. Her current projects include enhancing the production of pharmaceuticals in E. coli and developing advanced therapies for pancreatic cancer. In her spare time, Jen plays field hockey with the TarDevils adult team.</p> | ||
</td> | </td> | ||
− | |||
</tr> | </tr> | ||
<tr> | <tr> | ||
− | |||
<td align="center"><h4>Romel Menacho-Melgar</h4> | <td align="center"><h4>Romel Menacho-Melgar</h4> | ||
<p><br>Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals</p> | <p><br>Romel is a Biomedical Engineering PhD student. Originally from Peru, he came to the US to the University of South Carolina to earn a BS degree in Biomedical Engineering in 2009. He started his graduate studies at Duke in 2013 and joined the Lynch Lab in 2015. His project involves developing a platform for in vivo peptide lipidation for novel materials and pharmaceuticals</p> | ||
</td> | </td> | ||
+ | <td align="center"><img src="https://static.igem.org/mediawiki/2017/e/ef/T--Duke--Romel.png" style="width:243px;height:263px;"></td> | ||
</tr> | </tr> | ||
− | <tr> | + | <tr bgcolor= "#efefef"> |
+ | <td align="center"><img src="https://static.igem.org/mediawiki/2017/0/0b/T--Duke--Dan.jpg" style="width:217px;height:225px;"></td> | ||
<td align="center"><h4>Daniel Rodriguez</h4> | <td align="center"><h4>Daniel Rodriguez</h4> | ||
<p><br>My research focuses on constructing mathematical models of metabolic pathways that guide the engineering of bacteria for optimized chemical synthesis. An additional goal of my research is to elucidate more fundamental aspects of bacterial physiology, such as unknown metabolic control mechanisms, by investigating inconsistencies between in silico and in vivo behavior.</p> | <p><br>My research focuses on constructing mathematical models of metabolic pathways that guide the engineering of bacteria for optimized chemical synthesis. An additional goal of my research is to elucidate more fundamental aspects of bacterial physiology, such as unknown metabolic control mechanisms, by investigating inconsistencies between in silico and in vivo behavior.</p> | ||
</td> | </td> | ||
− | |||
</tr> | </tr> | ||
Line 138: | Line 142: | ||
</div> | </div> | ||
</html> | </html> | ||
+ | {{Duke/footer}} |
Latest revision as of 01:57, 2 November 2017
Our Wonderful Team of Advisors
Advisors
Michael Lynch
|
|
Adim Moreb
|
|
John Decker
|
Mentors
Johnathon Burg
|
|
Zhixia Ye
|
|
Charlie Cooper
|
|
Jennifer Hennigan
|
|
Romel Menacho-Melgar
|
|
Daniel Rodriguez
|